Streetbeat News

Analyst Ratings

TRVN

Trevena, Inc. (NASDAQ:TRVN) has completed the initial analysis of OLINVYK continuous respiratory monitoring data from the VOLITION study. The study assessed the potential impact of OLINVYK on respiratory, gastrointestinal (GI), and cognitive function outcomes in the postoperative setting.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 11:07 am

LYRA

HC Wainwright & Co. analyst Matthew Caufield has reiterated a 'Buy' rating on Lyra Therapeutics (NASDAQ:LYRA) and maintained a $12 price target.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 11:04 am

BIOR

HC Wainwright & Co. analyst Joseph Pantginis maintains a 'Buy' rating on Biora Therapeutics (NASDAQ:BIOR) but has lowered the price target from $65 to $50.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 11:01 am

MARA

Needham analyst John Todaro has initiated coverage on Marathon Digital Holdings (NASDAQ:MARA) with a Hold rating.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 10:41 am

SSTK

Needham analyst Bernie McTernan has reiterated a 'Buy' rating on Shutterstock (NYSE:SSTK) and maintained a price target of $76.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 10:38 am

ZI

Needham analyst Joshua Reilly maintains a 'Buy' rating on ZoomInfo Technologies (NASDAQ:ZI) but lowers the price target from $35 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 10:35 am

ESPR

Needham analyst Serge Belanger has reiterated a 'Buy' rating on Esperion Therapeutics (NASDAQ:ESPR) and maintained a $9 price target.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 10:31 am

BILL

Needham analyst Scott Berg has reiterated a 'Buy' rating on BILL Holdings (NYSE:BILL) and maintained a price target of $200.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 10:28 am

CRDO

Barclays analyst Thomas O'Malley has initiated coverage on Credo Technology Group (NASDAQ:CRDO) with an Overweight rating and a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 10:26 am

STKL

Mizuho analyst John Baumgartner has initiated coverage on SunOpta (NASDAQ:STKL) with a Buy rating and a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 10:24 am